Pipeline Overview

We are developing a diverse pipeline of product candidates for both rare and large market diseases, including patient populations that other gene therapies are unable to address. Our initial product candidates are focused in the following therapeutic areas: ophthalmology, cardiology and pulmonology. Each of our product candidates leverages a targeted and evolved vector we invented through our Therapeutic Vector Evolution platform.

4DMT THERAPEUTIC PIPELINE

Our Product Candidates

VECTOR
Delivery
PRODUCT
CANDIDATE
INDICATION
TVP
SELECTION
LEAD
OPTIM.
IND-
ENABLING
PHASE 1
PHASE 2
PHASE 3
PRODUCT
RIGHTS
R100
Intravitreal
OPHTHALMOLOGY
4D-125 XLRP
4D-110 CHM
4D-150 Wet AMD
DR/DME
C102
IV
CARDIOLOGY
4D-310 Fabry
Disease
A101
Aerosol
PULMONOLOGY
4D-710 Cystic Fibrosis

Our most advanced research and discovery programs

VECTOR
Delivery
PRODUCT
CANDIDATE
INDICATION
TVP
SELECTION
LEAD
OPTIM.
IND-
ENABLING
PHASE 1
PHASE 2
PHASE 3
PRODUCT
RIGHTS
R100
Intravitreal
OPHTHALMOLOGY
4D-135 adRP
C102
IV
CARDIOLOGY
4D-3XX Undisclosed
A101
Aerosol
PULMONOLOGY
4D-7XX Undisclosed